AOP Orphan Pharmaceuticals AG
Contact:
Dr. Christoph Klade
Phone:
E-Mail: christoph.klade@aoporphan.com
Contact:
Dr. Christoph Klade
Phone:
E-Mail: christoph.klade@aoporphan.com
KEYWORDS:
- EMA
- Ropeginterferon alfa-2b
- AOP Orphan Pharmaceuticals AG
attachments to announcement
AOP Orphan starts EMA marketing authorization application procedure for Ropeginterferon alfa-2b
back to announcementPDFs
 [ download PDF ] | title: Summary SK image text: AOP Orphan Pharmaceuticals AG copyright: AOP Orphan Pharmaceuticals AG |
[ download PDF ] | title: Summary IT image text: AOP Orphan Pharmaceuticals AG copyright: AOP Orphan Pharmaceuticals AG |
[ download PDF ] | title: Summary PL image text: AOP Orphan Pharmaceuticals AG copyright: AOP Orphan Pharmaceuticals AG |
[ download PDF ] | title: Summary HU image text: AOP Orphan Pharmaceuticals AG copyright: AOP Orphan Pharmaceuticals AG |
[ download PDF ] | title: Summary HR image text: AOP Orphan Pharmaceuticals AG copyright: AOP Orphan Pharmaceuticals AG |
[ download PDF ] | title: Summary ES image text: AOP Orphan Pharmaceuticals AG copyright: AOP Orphan Pharmaceuticals AG |
[ download PDF ] | title: Summary RU image text: AOP Orphan Pharmaceuticals AG copyright: AOP Orphan Pharmaceuticals AG |
[ download PDF ] | title: Summary FR image text: AOP Orphan Pharmaceuticals AG copyright: AOP Orphan Pharmaceuticals AG |
[ download PDF ] | title: Summary DK image text: AOP Orphan Pharmaceuticals AG copyright: AOP Orphan Pharmaceuticals AG |
[ download PDF ] | title: Summary CS image text: AOP Orphan Pharmaceuticals AG copyright: AOP Orphan Pharmaceuticals AG |
